We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Commercial Laboratory Now Offers Advanced Genomic Services

By LabMedica International staff writers
Posted on 20 Dec 2010
Clinicians and researchers can take advantage of a newly upgraded genomic services laboratory.

Ambry Genetics (Aliso Viejo, CA, USA) has recently launched their Illumina HiSeq 2000 Next Generation Sequencing Service. This advanced genomic service is based on the Illumina (San Diego, CA, USA) HiSeq 2000 sequencing system, which offers reversible terminator-based sequencing by synthesis chemistry in combination with innovative engineering. The HiSeq 2000 reputedly delivers the industry's highest sequencing output and fastest data generation rate. Its human interaction design features and easy sequencing workflow have set a new standard for simplicity and user experience.

Ambry Genetics has now become a Certified Service Provider (CSPRO) for the Illumina HiSeq 2000. Becoming a certified service provider required completing and passing the rigorous certification program set forth by Illumina. As a CSPRO, Ambry Genetics collaborates with Illumina to ensure the genetic analysis services provided to customers are the highest quality. In this regard, Ambry has built a reputation for service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research.

"We have continued to invest and develop our sequencing operations to become Illumina experts," said Ardy Arianpour, vice president of business development at Ambry Genetics. "All of our customers are excited about the Illumina HiSeq because it expands our whole genome and exome sequencing services to the next level and gives them the opportunity to reduce their costs while providing more data. If Illumina is your preferred platform then we want to be your preferred sequencing provider."

Related Links:
Ambry Genetics
Illumina




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Newborn Screening Test
NeoMass AAAC 3.0
New
FLU/RSV Test
Humasis FLU/RSV Combo

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests